Results 161 to 170 of about 9,440 (190)

Prevalence of allergen sensitization among asthmatic patients with serum total IgE >1000 IU/mL. [PDF]

Clin Transl Allergy
Wang W, Wu L, Li J, Hu Q.
europepmc   +1 more source

When common parasite turn uncommon: A rare case of Pulmonary Strongyloidiasis Hyperinfection syndrome in immunocompetent Adult. [PDF]

Lung India
Kadian K, Agarwal P, Goyal A, Khurana AK, Siddiqui F.   +4 more
europepmc   +1 more source

Selective targeting of IL-1RAP-dependent eosinophilic inflammation in allergic fungal airway disease

Williams TJ, Griffiths JS, Gonzales-Huerta LE, Bell D, Reed AK, Shah A, Naglik JR, Armstrong-James D.   +7 more
europepmc   +1 more source

Allergic bronchopulmonary aspergillosis

, 2011
openaire   +1 more source

Activation status of immune cells in the airway is a defining feature of severe fungal asthma

Plumpton EL, Colombo SA, Steward M, Brown SL, Khan S, Tavernier G, Francis H, Platt H, Hussell T, Horsnell W, Denning D, Niven R, Simpson A, MacDonald AS, Cook PC.   +14 more
europepmc   +1 more source

Allergic Bronchopulmonary Aspergillosis [PDF]

CHEST Journal, 1985
Allergic bronchopulmonary aspergillosis (ABPA) occurs as a complication of asthma. It presents as an infiltrative pulmonary disorder with respiratory and systemic symptoms, eosinophilia, elevated total serum IgE, and skin sensitizing, as well as precipitating antibodies to Aspergillus fumigatus. Sputum cultures are not always positive for the organism.
openaire   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Allergic bronchopulmonary aspergillosis

Journal of Allergy and Clinical Immunology, 1984
Allergic bronchopulmonary aspergillosis (ABPA) complicates asthma and cystic fibrosis. The survival factors in Aspergillus fumigatus that support saprophytic growth in bronchial mucus are not understood. Prednisone remains the most definitive treatment but need not be administered indefinitely.
Roy Patterson, Richard A. Mintzer, Anthony J. Ricketti, Paul A. Greenberger   +3 more
openaire   +7 more sources

Allergic Bronchopulmonary Aspergillosis

Clinics in Chest Medicine, 2022
Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic disorder caused by immune reactions against Aspergillus fumigatus. ABPA most commonly complicates the course of patients with poorly controlled asthma. Patients commonly present with uncontrolled asthma, fleeting pulmonary opacities, and bronchiectasis.
Ritesh, Agarwal, Valliappan, Muthu, Inderpaul S, Sehgal, Sahajal, Dhooria, Kuruswamy T, Prasad, Ashutosh N, Aggarwal   +5 more
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis

Proceedings of the American Thoracic Society, 2010
Allergic bronchopulmonary aspergillosis (ABPA) is a complex clinical entity that results from an allergic immune response to Aspergillus fumigatus, most often occurring in a patient with asthma or cystic fibrosis. Sensitization to aspergillus in the allergic host leads to activation of T helper 2 lymphocytes, which play a key role in recruiting ...
Karen, Patterson, Mary E, Strek
openaire   +2 more sources